Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Chronic kidney disease (CKD) represents a significant global public health concern, particularly in low- and middle-income countries, where more than 80% of stage 3 CKD cases remain undiagnosed due to the limited availability of effective screening tools. The urine albumin-to-creatinine ratio (UACR) is the reference standard for detecting albuminuria; however, point-of-care dipstick tests offer a feasible and cost-effective alternative in resource-constrained settings.
This cross-sectional diagnostic study was conducted at Srinagarind Hospital, Faculty of Medicine, Khon Kaen University, Thailand. Random midstream spot urine samples were evaluated using seven testing methods: 1) MicroalbuPHAN® (manual visual strip), 2) MicroalbuPHAN® with LAURA automated reader, 3) CYBOW 2AC (manual visual strip), 4) CYBOW 2AC with automated reader, 5) Thai-developed AL strip using competitive immunochromatography, 6) standard macro-protein dipstick, and 7) UACR measured by the Roche® analyzer (reference standard). Precision and linearity were assessed using albumin (10–150 mg/L) and creatinine (10–300 mg/dL) standards in triplicate. Manual readings were performed by trained personnel blinded to UACR results, while automated readings followed the manufacturers' protocols.
A total of 1,042 participants were enrolled, with a mean age of 62.53 ± 12.66 years and 52.78% being male. The prevalence of comorbidities included diabetes mellitus (59.79%), hypertension (52.88%), and CKD (26.01%). The mean estimated glomerular filtration rate (eGFR) was 67.96 ± 23.56mL/min/1.73 m², and the median UACR was 15.08 (IQR 4.62–83.39) mg/gCr. The lowest cost per test was observed with the macro-albumin strip, while the AL strip had the highest cost. Diagnostic performance for detecting UACR ≥ 30 mg/gCr varied across methods, with the highest receiver operating characteristic (ROC) area observed in strips coupled with automated readers. The strongest correlation with UACR was noted in the MicroalbuPHAN® with LAURA automated reader (r = 0.75), which also offered favorable economic value.
Semi-quantitative urine dipstick tests, especially when used with automated readers, demonstrate diagnostic performance comparable to laboratory-based UACR assessments at a reduced cost. These findings support the utility of such methods in CKD screening programs within resource-limited settings. Further studies incorporating clinical outcomes are recommended to validate their long-term efficacy.
